werewolftx.com - מחיר ריאלי לרכישת החברה במלואה HOWL
This chart of Werewolf Therapeutics (HOWL) price action on the GURU.Markets platform currently stands at 25.67. Werewolf Therapeutics develops innovative anti-tumor agents using PREDATOR technology to precisely target the disease without harming the body. The team consists of top experts attracted by large-scale grants, while the implementation of automated molecule screening systems significantly accelerates the creation of new drug formulas.
Werewolf Therapeutics, Inc. - פילוחים אנליטיים ומדדי מפתח (HOWL)
Enterprise Value (EV) represents the total acquisition price of a business, summing market capitalization and net debt. Investors utilize this parameter to assess the actual cost of buying an asset, accounting for its liabilities. By analyzing enterprise value levels, one can identify hidden stagnation or a capital accumulation phase. For Werewolf Therapeutics (HOWL), this metric reflects the market valuation of its cytokine platform potential. The stability of this indicator confirms institutional investors' confidence in management's roadmap.